Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus

BACKGROUND: The study of low-grade inflammation in patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular diseases is a pressing problem. A deeper understanding of the cascade of inflammatory reactions, possibly mediating the severe atherosclerotic lesions of various vascul...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vadim V. Genkel, Karina V. Nikushkina, Tansilla I. Nikonova, Igor I. Shaposhnik
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2018
Materias:	peripheral artery disease diabetes mellitus interleukin-6 interleukin-1β metformin Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/6238fb1e04424226b254e0d93641c02a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6238fb1e04424226b254e0d93641c02a
record_format	dspace
spelling	oai:doaj.org-article:6238fb1e04424226b254e0d93641c02a2021-11-14T09:00:21ZPeripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus2072-03512072-037810.14341/DM9392https://doaj.org/article/6238fb1e04424226b254e0d93641c02a2018-08-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9392https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378BACKGROUND: The study of low-grade inflammation in patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular diseases is a pressing problem. A deeper understanding of the cascade of inflammatory reactions, possibly mediating the severe atherosclerotic lesions of various vascular pools in patients with diabetes, has the potential to introduce more sophisticated diagnostic and therapeutic approaches into practice. AIM: To study the interrelation of low-grade inflammation and atherosclerosis of peripheral arteries in patients with coronary artery disease (CAD) and T2DM. MATERIALS AND METHODS: The study included 137 patients (77 men and 60 women) with CAD. The average age of patients was 62.0 (57.0–66.0) years. The first group included 67 patients with CAD and T2DM, and the second group included 70 patients with CAD. Low-grade inflammation was assessed by the levels of high-sensitivity C-reactive protein, interleukin (IL)-1β, IL-6, IL-8, IL-10 and TNF-α. All patients underwent duplex scanning of carotid arteries and lower extremity arteries (LEAs). RESULTS: Patients with CAD and T2DM showed significantly greater values of stenosis of carotid arteries and LEAs. Direct correlation was revealed between markers of inflammation and the degree of stenosis of the femoral and tibial arteries, as well as the intima-media thickness of the carotid and femoral arteries. In the group of patients with T2DM, the value of IL-1β was 2.04 (0.98–2.52) pg/mL, which was significantly less than 2.43 (1.84–3.19) pg/mL for patients in the second group (p = 0.010). The values of IL-6 were also significantly lower in the first group of patients, at 1.84 (0.73–4.41) pg/mL vs. 3.73 (2.27–10.2) pg/mL in the first and second groups, respectively (p = 0.008). The dose of metformin was inversely correlated with the level of IL-6 (r = −0.314, p = 0.003). CONCLUSIONS: Patients with CAD and T2DM compared with patients without diabetes had significantly greater values of stenosis of peripheral arteries. The levels of IL-1β and IL-6 in the group of patients with CAD and T2DM were significantly lower in comparison with patients without diabetes. The dose of metformin was inversely correlated with the level of IL-6.Vadim V. GenkelKarina V. NikushkinaTansilla I. NikonovaIgor I. ShaposhnikEndocrinology Research Centrearticleperipheral artery diseasediabetes mellitusinterleukin-6interleukin-1βmetforminNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 21, Iss 3, Pp 178-185 (2018)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	peripheral artery disease diabetes mellitus interleukin-6 interleukin-1β metformin Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	peripheral artery disease diabetes mellitus interleukin-6 interleukin-1β metformin Nutritional diseases. Deficiency diseases RC620-627 Vadim V. Genkel Karina V. Nikushkina Tansilla I. Nikonova Igor I. Shaposhnik Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
description	BACKGROUND: The study of low-grade inflammation in patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular diseases is a pressing problem. A deeper understanding of the cascade of inflammatory reactions, possibly mediating the severe atherosclerotic lesions of various vascular pools in patients with diabetes, has the potential to introduce more sophisticated diagnostic and therapeutic approaches into practice. AIM: To study the interrelation of low-grade inflammation and atherosclerosis of peripheral arteries in patients with coronary artery disease (CAD) and T2DM. MATERIALS AND METHODS: The study included 137 patients (77 men and 60 women) with CAD. The average age of patients was 62.0 (57.0–66.0) years. The first group included 67 patients with CAD and T2DM, and the second group included 70 patients with CAD. Low-grade inflammation was assessed by the levels of high-sensitivity C-reactive protein, interleukin (IL)-1β, IL-6, IL-8, IL-10 and TNF-α. All patients underwent duplex scanning of carotid arteries and lower extremity arteries (LEAs). RESULTS: Patients with CAD and T2DM showed significantly greater values of stenosis of carotid arteries and LEAs. Direct correlation was revealed between markers of inflammation and the degree of stenosis of the femoral and tibial arteries, as well as the intima-media thickness of the carotid and femoral arteries. In the group of patients with T2DM, the value of IL-1β was 2.04 (0.98–2.52) pg/mL, which was significantly less than 2.43 (1.84–3.19) pg/mL for patients in the second group (p = 0.010). The values of IL-6 were also significantly lower in the first group of patients, at 1.84 (0.73–4.41) pg/mL vs. 3.73 (2.27–10.2) pg/mL in the first and second groups, respectively (p = 0.008). The dose of metformin was inversely correlated with the level of IL-6 (r = −0.314, p = 0.003). CONCLUSIONS: Patients with CAD and T2DM compared with patients without diabetes had significantly greater values of stenosis of peripheral arteries. The levels of IL-1β and IL-6 in the group of patients with CAD and T2DM were significantly lower in comparison with patients without diabetes. The dose of metformin was inversely correlated with the level of IL-6.
format	article
author	Vadim V. Genkel Karina V. Nikushkina Tansilla I. Nikonova Igor I. Shaposhnik
author_facet	Vadim V. Genkel Karina V. Nikushkina Tansilla I. Nikonova Igor I. Shaposhnik
author_sort	Vadim V. Genkel
title	Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_short	Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_full	Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_fullStr	Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_full_unstemmed	Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_sort	peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
publisher	Endocrinology Research Centre
publishDate	2018
url	https://doaj.org/article/6238fb1e04424226b254e0d93641c02a
work_keys_str_mv	AT vadimvgenkel peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus AT karinavnikushkina peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus AT tansillainikonova peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus AT igorishaposhnik peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus
_version_	1718429531904147456

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus

Ejemplares similares